Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation

Tracheal intubation without neuromuscular blocking agents

tracheal intubation without the use of neuromuscular blocking agents

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents

I read with keen interest the article by Imani et al. (1) in which the authors compare tracheal intubating conditions following intravenous (IV) administration of remifentanil 5 μg/kg or alfentanil 50 μg/kg followed by induction of anesthesia with propofol 2 mg/kg in 100 adult patients premedicated with IV midazolam 1 mg. Intubating conditions were assessed (scoring 1 to 4) by ease of laryngosc...

Tracheal intubation without neuromuscular blocking drugs in children.

Morton, N. S. (2009) Tracheal intubation without neuromuscular blocking drugs in children. Paediatric Anaesthesia, 19(3). pp. 199-201. Copyright © 2009 Blackwell Publishing Ltd. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge Content must not be changed in any way or reproduced in any format or medium without the formal permission of th...

The pharmacology of atracurium: a new competitive neuromuscular blocking agent.

Atracurium besylate, 2,2'-(3,11-dioxo-4,10-dioxatridecylene)-bis-[6,7-dimethoxy-1-(3,4-dimethoxy-benzyl)-2-methyl-1,2,3,4-tetrahydroisoquinolinium] dibenzenesulphonate, is one of a new series of competitive neuromuscular blocking agents. An i.v. dose of 0.25 mg kg-1 produced complete paralysis in anaesthetized cats, dogs and rhesus monkeys; paralysis was of medium duration and was readily antag...